Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

22 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Cohort 1: hatg, csa, epag day 14 to month 6 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
2 Cohort 2: hatg, csa, epag day 14 to month 3 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
3 Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
4 Enalapril Enalapril 2件: D00621, D07892 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 7件: 19, 46, 66, 113, 210, 222, 223 💬
5 Enalapril and other angiotensin converting enzyme inhibitors Angiotensin II 4件: D00150, D00621, D02014, D07892 💬 3件: ACE, AGTR1, AGTR2 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 19 💬
6 Enalapril maleate Enalapril 2件: D00621, D07892 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 1件: 46 💬
7 Enalapril valsartan methylprednisone Enalapril 3件: D00400, D00621, D07892 💬 2件: ACE, AGTR1 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 66 💬
8 Epa - - - - 6件:  8 , 46, 48, 49, 113, 301 💬
9 Epa and dha - - - - 1件: 113 💬
10 Epa and dha supplementation - - - - 2件: 48, 49 💬
11 Epadel - - - - 1件: 296 💬
12 Epanova - - - - 1件: 96 💬
13 Epanova™ (omega-3 free fatty acids) Omega-3 fatty acids - - - 1件: 96 💬
14 Eparmefolin 30 cpr 0,1/0,5mg - - - - 1件: 13 💬
15 Epatuzumab - - - - 1件: 49 💬
16 Epax 6000 ee 1000mg (0.6 gr dha+epa) - - - - 1件: 46 💬
17 Epaxal - - - - 1件: 46 💬
18 Epaxal berna (virosomal hepatitis a vaccine) Hepatitis A Vaccine - - - 2件: 96, 97 💬
19 Ethyl-epa Icosapent ethyl 1件: D01892 💬 - - 1件:  8  💬
20 Ethyl-epa (miraxion™) Icosapent ethyl 1件: D01892 💬 - - 1件:  8  💬
21 Hepatitis a vaccine ( havrix or epaxal) Hepatitis A Vaccine - - - 1件: 46 💬
22 Over the counter dha/epa dietary supplementation - - - - 1件: 301 💬

先頭へ